Navigation Links
Synergy 185 UV Ultrapure Water System

ProductsSynergy 185 UV Ultrapure Water System
Company Millipore
Item Synergy 185 UV Ultrapure Water System
Features Inquire
Description Water for Basic Laboratory Needs
Synergy systems produce ultrapure water from pre-treated water at a flow rate from 1 to 1.2 L/min to meet the basic needs of scientific laboratories. The Synergy 185 system incorporates a dual-wavelength UV lamp (185 nm and 254 nm) to produce water with low levels of organic contaminants (< 5 ppb TOC when fed by Elix water). Water quality is easily monitored on the system's two-line alphanumeric display and can be viewed as Resistivity (MWcm) or Conductivity (S/cm), temperature-compensated or not, as required by USP 24.

Applications

  • Preparation of buffers for liquid chromatography
  • Biochemical experiments
  • Isocratic or gradient solutions for HPLC analysis
  • Culture media for bacteriological analysis or cell cultures
  • Solutions for spectrophotometry, spectroscopy, and other analytical techniques
Features
  • Feedwater specific purification packs snap-in and snap-out for replacement
  • Built-in dispense timer for fixed delivery of water between 1 and 45 minutes
  • System monitor automatically informs when cartridge exchange is required
  • System monitor automatically informs when UV lamp needs replacing
  • Automatic recirculation allows system to maintain water quality in between periods of use
Info Millipore
Customer Service: (978) 715-4321
Web site: http://www.millipore.com/

Related medicine products :

1. Synergy HT Multi-Detection Microplate Reader
2. Medelec Synergy N-EP
3. Medelec Synergy T-EP
4. Teca Synergy N-EP
5. Teca Synergy T-EP - EMG/EP Monitoring Systems
6. Synergy Ultrapure Water System
7. SynergyPlus™ Neurostimulation System
8. arium 611 Ultrapure Water Systems
9. arium Water Tower Integrated Reverse Osmosis and Ultrapure Water System
10. HydroKeratome Waterjet System
11. US Autoflow Single Chamber Stackable Water-Jacketed CO2/O2 Inc.
Breaking Medicine Technology:Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 2Echo Therapeutics Announces Consulting Agreement with Hayden IR to Develop and Implement a Strategic Investor Relations Campaign 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3The American Academy of Pediatrics Names Lu Ann Papile M D FAAP as Chair of the Fetus and Newborn Committee 50871 1The American Academy of Pediatrics Names Lu Ann Papile M D FAAP as Chair of the Fetus and Newborn Committee 50871 2The American Academy of Pediatrics Names Lu Ann Papile M D FAAP as Chair of the Fetus and Newborn Committee 50871 3Nutrition 21 Launches New Innovative PRESCRIPTIX 28TM 29 Nutraceuticals Product Line 50867 1Nutrition 21 Launches New Innovative PRESCRIPTIX 28TM 29 Nutraceuticals Product Line 50867 2Nutrition 21 Launches New Innovative PRESCRIPTIX 28TM 29 Nutraceuticals Product Line 50867 3Nutrition 21 Launches New Innovative PRESCRIPTIX 28TM 29 Nutraceuticals Product Line 50867 4Nutrition 21 Launches New Innovative PRESCRIPTIX 28TM 29 Nutraceuticals Product Line 50867 5AEterna Zentaris 3A New Data Published on its Ghrelin Antagonist Compound AEZS 123 28JMV2959 29 Supports its Use in Alcohol Addiction 12909 1AEterna Zentaris 3A New Data Published on its Ghrelin Antagonist Compound AEZS 123 28JMV2959 29 Supports its Use in Alcohol Addiction 12909 2AEterna Zentaris 3A New Data Published on its Ghrelin Antagonist Compound AEZS 123 28JMV2959 29 Supports its Use in Alcohol Addiction 12909 3AEterna Zentaris 3A New Data Published on its Ghrelin Antagonist Compound AEZS 123 28JMV2959 29 Supports its Use in Alcohol Addiction 12909 4